Commercialization

NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)

Conference Call Today at 9:00am ET Covers Europe, Middle East and Africa Includes Licensing Option and Development Funding for NGX-1998 SAN MATEO, Calif. and STAINES, England, June 22 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ) and Astellas Pharma ...

AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast

TUSTIN, Calif., June 17 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today its Chairman and CEO Mr. Douglas MacLellan has been featured in CEOCFO Magazine - a daily online investment news publication t...

AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada

TUSTIN, Calif., May 13 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today it has entered into two distinct five-year marketing and distribution agreements with GenWay Biotech, Inc., a global protein and a...

Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications

SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) and its subsidiary Tissue Repair Company (TRC) today announced significant new formulation enhancements for its Excellarate(TM) product candidate that are designed to simplify and broaden the use of Excellarate for...

Tech Award Recognizes Vocantas for Commercialization Partnership, Development of World-leading Chronic Disease Management Solution

OTTAWA, April 17 /PRNewswire/ - Vocantas Inc., a developer of automated outreach solutions, was honoured to receive the Technology Commercialization Partnership award at the 14th annual OCRI Awards. The award was presented to Vocantas for the collective research and development that resulted in th...

Best Practice Database Adds Research Highlighting the Value of Portfolio Management in Early-Stage Commercialization and Customer-Focused Software Quality Assurance

CHAPEL HILL, N.C., March 31 /PRNewswire/ -- New research that delivers timely studies on vital groups such as quality and early-stage commercialization is now available in the Best Practice Database, an online research repository managed by research and consulting firm Best Practices, LLC. To...

CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center

SEATTLE, Feb. 27 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has started a collective dismissal procedure pursuant to Law 223/1991 concerning its Bresso, Italy, (CTE) employees. The collective dismissal will involve a total of 62 employee...

The Commercialization Funding Coach, Fred Patterson, Weighs In On SBIR Funding for Small Business Ventures in Wake of NIH Exclusion

The Commercialization Funding Coach, Inc. proprietor, Fred Patterson, has weighed in on the future of SBIR grants in Washington, DC as a means of funding for small business ventures in the wake of SBIR grants being explicitly excluded from NIH stimulus money. Federal reauthorization or a continui...

Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel

-- Portola to Receive $75 Million Upfront Cash Payment, $500 Million in Potential Milestone Payments Plus Royalties on Future Sales -- SOUTH SAN FRANCISCO, Calif., Feb. 12 /PRNewswire/ -- Portola Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative drugs tha...

Best Practice Database adds Research Highlighting the Value of Internal Consulting and Early-Stage Commercialization Groups in the Pharmaceutical Industry

CHAPEL HILL, N.C., Feb. 9 /PRNewswire/ -- New research that delivers timely studies with operational insights on vital groups such as internal consulting and early-stage commercialization is now available in the Best Practice Database, an online research repository managed by research and cons...

Commercialization in Medical Technology

Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays

MARSEILLE, France, May 4 /PRNewswire-FirstCall/ -- Ipsogen SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, the manufacturing and the commercialization of diagnostic assays for breast cancer and leukemia, today announces the signature of an ...

Wayne County Partners With TechTown to Launch Global Stem Cell 'Innovation and Commercialization Lab'

2,500-square-foot 'open lab' will serve as international hub for collaborative research, biotech start-ups DETROIT, Feb. 16 /PRNewswire-USNewswire/ -- TechTown, the Wayne State University research and technology park, will soon be home to the first stem cell commercialization lab in Michiga...

Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference

- Albuferon(R) for hepatitis C, LymphoStat-B(R) for lupus and ABthrax(R) for inhalation anthrax all progressing rapidly toward commercialization - - GSK Phase 3 trial of darapladib underway in chronic coronary heart disease - - HGS provides 2009 financial guidance; expects less than $25 ...

Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin

SOUTH SAN FRANCISCO, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, announced today that it will be exploring strategic alternatives for its preclinical research programs in order to a...

Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology

MENLO PARK, Calif., Jan. 16 /PRNewswire/ -- Fundamental Applied Biology, Inc. (FAB) announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase IIB grant from the National Science Foundation. The $500,000 grant will be used to continue to develop FAB's cell-free ...

Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe

PRINCETON, N.J. and FOSTER CITY, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY ) and Gilead Sciences, Inc. (Nasdaq: GILD ) today announced an agreement to commercialize ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)...

Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization

DOYLESTOWN, Pa., May 14 /PRNewswire-FirstCall/ -- The Quigley Corporation (Nasdaq: QGLY ) announced positive results from a study conducted by its wholly owned subsidiary, Quigley Pharma Inc., which was conducted in chickens to evaluate the anti-viral activity of its compound QR448(a). The co...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...iety of diseases. Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... and we are currently in discussions with potential partners to support the commercialization of our product in Canada." Labopharm's NDS is based on data from five piv...ous countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. Investors should...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

...ess between $20 and $30 million in clinical development expenses. Access is currently in discussion with potential partners for development and commercialization of ProLindac in additional territories. About ProLindac(TM): ProLindac is a novel DACH platinum prodrug which has been shown to be active i...

Commercialization in Medical Products

Anti-HCV Low Titer Performance Panel

Features:...providing the major US and international screening, diagnostic and confirmatory test results. The panel is a useful tool for design, development, and commercialization comparisons of new anti-HCV assays. Convenient 1.0 ml packaging size. Provides sufficient volume for determinations in all major test systems....
Company:BBI Diagnostics

Anti-HTLV Mixed Titer Performance Panel

Features:...roviding the major US and international screening, diagnostic, and confirmatory test results. The panel is a useful tool for design, development, and commercialization comparisons of new anti-HTLV assays. Convenient 0.5 ml packaging size. Provides sufficient volume for determinations in all major test systems....
Company:BBI Diagnostics

Worldwide HCV Performance Panel

Features:..., HCV genotype, quantitative RNA, Ag, RIBA and line probe confirmatory, and EIA screening. The panel is a useful tool for design, development, and commercialization comparisons of new anti-HCV assays. Convenient 0.5 ml packaging size. ...
Company:BBI Diagnostics

Commercialization in Biological News

UTMB inventions win University of Texas System commercialization awards

GALVESTON, Texas Two inventions created by University of Texas Medical Branch at Galveston researchers have won $50,000 awards from the Texas Ignition Fund, a new program designed to spur the commercialization of technologies developed at UT System institutions. One of the inventions, conceive...

IEEE Homeland Security Conference Business Panel to feature experts on technology commercialization

WASHINGTON (7 May 2008) -- Dr. Thomas Cellucci, chief commercialization officer for the Department of Homeland Security (DHS) Science and Technology (S&T) Directorate; and Peter Ciganer, executive vice president, In-Q-Tel, will be featured Business Panel speakers at the 2008 IEEE International Con...

World's largest ocean observatory takes shape

...port security and shipping, resource development, sovereignty and security, and ocean management. Its cutting-edge technologies are already generating commercialization and job creation opportunities. "Today's launch demonstrates Canada as a global leader in ocean research," says the parliamentary secretary to the ...

CWRU receives $5 million from Ohio Third Frontier Commission

...hio's Third Frontier Commission under the Research commercialization Program. The funding will help support new and inn...will result in efficient clinical applications and commercialization of stem cells to benefit patients throughout Ohio....cancer. The goal of this project is to advance the commercialization of MultiStem cell therapy by running a FDA approve...

Another JDRF partner moves research forward with collaboration agreement for diabetes treatment

...o treat and cure type 1 diabetes, in order to attract funding for potential commercialization from large drug companies," said Alan J. Lewis, PhD, President and Chief Ex...tibody with Lilly; and Canada's Transition Therapeutics, which has signed a commercialization agreement for a beta cell regenerative therapy with Lilly. Bayhill's BHT...

Partnership to accelerate Trudeau Institute discoveries to patient care

...rporated (HRI) have established a unique partnership aimed at advancing the commercialization of medical and scientific discoveries made at the institute to maximize the...ished hundreds of patents and technology licenses that have resulted in the commercialization of medical advancements, such as the Prostate Specific Antigen test ("PSA t...

Triage technology with a Star Trek twist

...d further testing of optical stabilization technology to make sure the unit can function despite a responder's arm and hand movements. Transition and commercialization could occur sometime mid to late 2010. The final frontier for the SPTT, of course, is the first responders themselves. S&T's Tech Solutions wants ...

Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics

... Light Sources from 3 to 300 m Wavelength" on Wednesday, June 3, tracing the path from invention to exciting advances in the physics, applications and commercialization of these revolutionary lasers, which cover the mid- and far-ir spectrum and are broadly impacting sensing, spectroscopy, and sub-wavelength photonics....

GenWay Biotech obtains exclusive rights to AMDL's DR-70 cancer test in US and Canada

...ratories in the United States and for lung cancer screening in Canada. The commercialization efforts include raising awareness of the disease and demand creation for th...and life-saving potential of this test personally drives our motivation for commercialization success." The market potential for DR-70 is significant with an estimate...

Regional partnership to develop algal biofuels gets backing of San Diego leaders

..."SD-CAB." The primary goal of the center is to create a national facility capable of developing and implementing innovative research solutions for the commercialization of fuel production from algae. "By sharing and facilitating the interactions of these multiple researchers through this center, we hope to make sus...

Commercialization in Biological Technology

SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS

SAN DIEGO, CA AND GENEVA, SWITZERLAND, August 3, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply indus...

BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol

CAMBRIDGE, Mass., July 29 /PRNewswire-FirstCall/ -- BP and Verenium Corporation (Nasdaq: VRNM ) today announced that its 50-50 joint venture company will operate under the name Vercipia Biofuels, and plan to relocate its corporate headquarters to Florida. Vercipia continues to foc...

Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals

UPPSALA, Sweden, June 29 /PRNewswire/ -- - Financing Led by SLS Invest Will Fund Gyros to Profitability Gyros AB, the leading provider of automated micro-immunoassays for therapeutic protein development, announces that it has raised SEK 80 million (approximately euro 7.5 million)...

ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program

CLEVELAND, May 6 /PRNewswire/ -- ChanTest, the leading expert in ion channels and GPCRs (G-protein coupled receptors) -- key to drug discovery, development, and safety -- is one of eight organizations slated to receive funding through Ohio's Third Frontier Research and Commercialization Program. G...

SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO., INC.

SAN DIEGO, CA, March 24, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today the extension of one of it...

AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia

All amounts are in US dollars QUEBEC CITY, March 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the signing of a development, commercialization and licensing agreement ...

ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Dec. 8 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received FDA clearance for the marketing of the ATS 3f(R) Aortic Bioprosthesis that includes a new sewing t...

SENOMYX AND FIRMENICH TO COLLABORATE ON COMMERCIALIZATION OF S2383, A NOVEL ENHANCER OF THE HIGH-INTENSITY SWEETENER SUCRALOSE

- Collaboration will utilize Firmenich's world leadership in the commercialization of flavor ingredients - New S2383 flavor enhancer may be used in beverages, foods and oral care healthcare products to reduce the need for sucralose SAN DIEGO, CA AND GENEVA, SWITZER...

Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes

NEW YORK and SAN DIEGO, Oct. 23, 2008 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX ) and Phenomix Corporation today announced that they have entered into a definitive collaboration agreement to develop and commercialize dutogliptin (PHX1149) in North America. Dutogliptin is ...

Can Algae Biofuels Satisfy the World's Growing Biofuel Needs? Upcoming Webinar Shares the Latest Commercialization Strategies and Challenges

Two leading Algae experts will share their views on the commercialization prospects of Algae Biofuels at the upcoming "Algae Biofuels: The REAL Story" webinar. This webinar separates facts from fiction and will provide a critical examination of several key issues central to long-term co...

Commercialization in Biological Dictionary

Technology transfer

...logy , tech trans ... Planning to establish a technology transfer and commercialization function at ... Works to transfer and enable commercialization of NASA-JSC technologies to the private sector to create jobs, improve prod...

Antibody

...nce perceived ... Over 30000 antibody / antibodies , 16000 Recombinant Protein/Proteins, 15000 Chimera RNAi and more... Antibody School. Reagent commercialization ... Antibody -- Biotechnology Stocks ... An antibody is a protein complex used by the immune system to identify and ... Presently, many ant...